21 Jul 2020 --- NZMP has gained a European patent for SureStart MFGM Lipid 100 and MFGM Lipid 70. Customers using the lipid ingredients can now position their infant formula products as “beneficial for cognitive development.” The patent contains claims for maternal and pediatric formulations that contain complex lipids, including gangliosides for increasing cognitive development. Likewise, it provides “that extra reassurance” that end-consumers are purchasing a “high-quality, innovative product with benefits that are backed by robust science,” details the company.
